HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A crossover trial of oxdralazine in hypertension.

Abstract
Twenty-nine moderate and severe essential hypertensive patients completed a crossover study aimed at evaluating efficacy and tolerability of a double combination (chlorthalidone plus propranolol) and of a triple combination (chlorthalidone plus oxdralazine plus propranolol). After one month on 25 mg/day chlorthalidone, which caused nonsignificant reduction in blood pressure of 7/4 mm Hg, patients were randomized to receive either the double or triple regimen for a three-month period. Then, after another month on chlorthalidone alone at the same dose of 25 mg/day, treatments were crossed over and the study continued for another three-month period. The double regimen caused a drop in pressure of 16/11 mm Hg after one month (daily doses 25 mg chlorthalidone, 103 +/- 25 mg propranolol), and this reduction did not change at the third month in spite of dosage increases (daily doses 25 mg chlorthalidone, 222 +/- 77 mg propranolol). The triple regimen reduced blood pressure 35/15 mm Hg after one month (daily doses 25 mg chlorthalidone, 20 mg oxdralazine, 40 mg propranolol), and further increase in dosages caused a reduction of 45/24 mm Hg at the third month (daily doses 25 mg chlorthalidone, 56 +/- 20 mg oxdralazine, 112 +/- 40 mg propranolol). Both treatments were well tolerated; in particular, at the end of the third month of each treatment period, 25 patients on the triple regimen achieved a stable diastolic blood pressure of 90 mm Hg or less, as compared to 10 patients on the double regimen (P less than 0.01).
AuthorsA Salvadeo, G Villa, S Segagni, F Galli, D Criscuolo
JournalJournal of clinical pharmacology (J Clin Pharmacol) Vol. 23 Issue 4 Pg. 155-60 (Apr 1983) ISSN: 0091-2700 [Print] England
PMID6345596 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antihypertensive Agents
  • Ethanolamines
  • Pyridazines
  • Propranolol
  • oxdralazine
  • Chlorthalidone
Topics
  • Adult
  • Antihypertensive Agents (administration & dosage, adverse effects)
  • Blood Pressure (drug effects)
  • Chlorthalidone (administration & dosage)
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Ethanolamines (administration & dosage, adverse effects)
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Propranolol (administration & dosage)
  • Pyridazines (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: